The changing role of radiation therapy in the management of oligometastatic disease
It is clear from surgical series that there are selected patients presenting with localised metastatic disease who can be cured by radical ablation of the metastasis. To date this has been limited to surgical resection but the evolution of stereotactic ablative body radiotherapy (SABR) has opened ne...
Main Authors: | H. Tharmalingham, P.J. Hoskin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-03-01
|
Series: | Technical Innovations & Patient Support in Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405632417300021 |
Similar Items
-
Oligometastatic prostate cancer: diagnosis and preliminary results of radiation therapy
by: F. R. Dzhabarov, et al.
Published: (2020-07-01) -
Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
by: Sabine Gerum, et al.
Published: (2018-05-01) -
Role of SRS/SBRT in Oligometastatic Disease.
Published: (2020) -
Multimodal therapy in urachal carcinoma with oligometastatic bone disease
by: C. García Alvarez, et al.
Published: (2019-09-01) -
Stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic prostate cancer
by: Kamran Ali Ahmed, et al.
Published: (2013-01-01)